Form 4/A for AORT ARTIVION, INC.

Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-01 · accession 0000784199-24-000128 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
A	2024-03-14	2024-03-01	AORT	Stanton Marshall S.	SVP, Clinical, MD Affair	S - Sale	$18.72	-1,506	85.5K	-2%	-$28.2K
A	2024-03-14	2024-03-01	AORT	Stanton Marshall S.	SVP, Clinical, MD Affair	A - Grant	$0.00	+5,724	87.0K	+7%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-03-01	S	D	1,506	$18.72	85,479	D	—	—	(F3) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. (F2) As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
2	Common	Common Stock	2024-03-01	A	A	5,724	$0.00	86,985	D	—	—	(F1) Represents LTIP performance stock units of which one hundred percent (100%) were issued on March 1, 2024. (F2) As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.